MDGL Stock Balance Sheets

Madrigal Pharmaceuticals Quarterly Balance Sheets Chart

Quarterly

Annual

Cash and Cash Eq

Account Payables

Inventory

Madrigal Pharmaceuticals Quarterly Balance Sheets Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-09-30	2018-06-30	2018-03-31	2017-09-30	2017-06-30	2017-03-31	2016-09-30	2016-06-30	2016-03-31	2015-09-30	2015-06-30	2015-03-31	2014-09-30	2014-06-30	2014-03-31	2013-09-30	2013-06-30	2013-03-31	2012-09-30	2012-06-30	2012-03-31	2011-09-30	2011-06-30	2011-03-31	2010-06-30	2010-03-31	2009-09-30	2007-09-30	2007-06-30

assets
current assets:
cash and cash equivalents	186,193,000	183,646,000	100,019,000	232,684,000	494,597,000	622,517,000	99,915,000	62,055,000	77,196,000	113,308,000	331,549,000	59,340,000	53,272,000	42,282,000	36,269,000	49,174,000	33,540,000	44,205,000	54,004,000	109,120,000	61,867,000	66,651,000	46,697,000	89,486,000	72,508,000	47,493,000	38,046,000	264,861,000	38,125,000	12,960,000	34,797,000	8,215,000	8,393,302	10,756,000	42,815,000	45,537,000	32,003,000	33,255,000	68,478,000	96,811,000	52,034,000	25,477,000	33,783,000	34,962,000	29,442,000	25,593,000	34,550,000	20,643,000	25,891,000	17,372,000	42,611,000	57,917,000	34,803,000		64,526,000
restricted cash	5,000,000	5,000,000	5,000,000	5,000,000	5,000,000																																																83,000		83,000
marketable securities	610,831,000	659,422,000	826,232,000	765,943,000	563,197,000	436,546,000	534,216,000	170,296,000	221,222,000	216,169,000	27,225,000	93,852,000	158,494,000	177,671,000	234,077,000	249,970,000	290,306,000	263,019,000	230,145,000	226,817,000	322,513,000	341,859,000	392,348,000	364,124,000	393,888,000	430,332,000	450,492,000	225,444,000	144,700,000	49,177,000	32,369,000	31,912,000	31,164,553	32,259,000	9,227,000	42,715,000	66,331,000	43,351,000	50,802,000	15,249,000	26,753,000	27,907,000	36,420,000	55,432,000	25,697,000	19,063,000	22,840,000	30,017,000	36,998,000	22,861,000	6,047,000		16,942,000
trade receivables	79,231,000	61,428,000	53,822,000	30,463,000	6,899,000
inventory	63,497,000	55,241,000	34,068,000	8,715,000	7,072,000	854,000
prepaid expenses and other current assets	58,604,000	23,242,000	13,786,000	20,861,000	14,963,000	14,035,000	3,150,000	3,118,000	3,177,000	1,807,000	2,595,000	3,920,000	2,780,000	1,217,000	1,338,000	3,812,000	2,221,000	822,000	1,014,000	1,664,000	2,223,000	976,000	1,152,000	1,712,000	2,389,000	565,000	767,000	968,000	374,000	583,000	781,000	225,000	1,632,783	1,820,000	554,000	1,975,000	2,213,000	1,367,000	2,911,000	2,264,000	1,605,000	1,358,000	1,637,000	1,475,000	803,000	839,000	608,000	1,362,000	832,000	524,000	721,000	1,011,000	1,112,000		1,315,000
total current assets	1,003,356,000	987,979,000	1,032,927,000	1,063,666,000	1,091,728,000	1,073,952,000	637,281,000	235,469,000	301,595,000	331,284,000	361,369,000	157,112,000	214,546,000	221,170,000	271,684,000	302,956,000	326,067,000	308,046,000	285,163,000	337,601,000	386,603,000	409,486,000	440,197,000	455,322,000	468,785,000	478,390,000	489,305,000	491,273,000	183,199,000	62,720,000	67,947,000	40,352,000	41,190,638	44,835,000	52,596,000	90,227,000	100,547,000	77,973,000	122,191,000	114,324,000	80,392,000	54,742,000	71,840,000	91,869,000	55,942,000	45,495,000	57,998,000	52,022,000	63,721,000	40,757,000	49,379,000	58,928,000	52,940,000		65,924,000
property and equipment	1,615,000	1,901,000	2,190,000	2,268,000	1,695,000	1,742,000	1,553,000	659,000	455,000	512,000	601,000	701,000	789,000	796,000	851,000	844,000	891,000	978,000	1,047,000	1,153,000	1,265,000	1,373,000	1,184,000	181,000	211,000	240,000	244,000	255,000	279,000	111,000	120,000	5,000	1,476	103,000	374,000	561,000	714,000	855,000	1,134,000	1,264,000	1,408,000	1,488,000	1,620,000	1,350,000	1,205,000	1,166,000	1,324,000	1,316,000	1,403,000	1,752,000	3,020,000	3,463,000	4,554,000		5,589,000
intangible assets	4,548,000	4,639,000	4,729,000	4,819,000	4,910,000	5,000,000
right-of-use asset	5,862,000	2,110,000	2,401,000	2,512,000	1,456,000	1,586,000	1,713,000	1,836,000	411,000	653,000	602,000	831,000	1,057,000	696,000	797,000	897,000	997,000	707,000	785,000	863,000	520,000	598,000	675,000	751,000	826,000	930,000
total assets	1,015,381,000	996,629,000	1,042,247,000	1,073,265,000	1,099,789,000	1,082,280,000	640,547,000	237,964,000	302,461,000	332,449,000	362,572,000	158,644,000	216,392,000	222,662,000	273,332,000	304,697,000	327,955,000	309,731,000	286,995,000	339,617,000	388,388,000	411,457,000	442,056,000	456,254,000	469,822,000	479,560,000	489,549,000	491,528,000	183,478,000	62,831,000	68,067,000	40,357,000	41,507,184	44,938,000	52,970,000	91,014,000	101,539,000	79,392,000	123,656,000	115,946,000	82,184,000	56,663,000	73,924,000	93,700,000	57,613,000	47,164,000	59,841,000	53,868,000	65,621,000	42,926,000	52,550,000	62,542,000	57,562,000		71,600,000
liabilities and stockholders’ equity
current liabilities:
accounts payable	37,975,000	42,056,000	43,599,000	45,966,000	8,994,000	21,528,000	28,041,000	16,542,000	17,534,000	12,128,000	23,831,000	18,562,000	11,294,000	22,780,000	21,380,000	10,418,000	1,067,000	4,396,000	1,017,000	6,277,000	5,004,000	1,115,000	1,178,000	773,000	446,000	4,376,000	1,031,000	588,000	1,420,000	1,400,000	1,285,000	2,780,000	1,159,836	680,000	744,000	1,424,000	3,018,000	3,738,000	4,442,000	5,226,000	5,810,000	5,693,000	5,222,000	5,719,000	3,690,000	3,468,000	3,040,000	2,921,000	1,999,000	1,691,000	1,280,000	1,462,000	4,536,000		1,981,000
accrued liabilities	157,479,000	124,165,000	124,695,000	131,003,000
lease liability	1,049,000	1,016,000	983,000	878,000	557,000	542,000	527,000	513,000	411,000	653,000	602,000	760,000	879,000	413,000	410,000	406,000	403,000	320,000	318,000	315,000	323,000	319,000	315,000	310,000	306,000	302,000
total current liabilities	196,503,000	167,237,000	169,277,000	177,847,000	125,162,000	114,341,000	118,548,000	99,665,000	99,706,000	98,348,000	115,894,000	98,920,000	84,009,000	76,635,000	76,838,000	69,325,000	56,710,000	48,791,000	46,557,000	49,365,000	45,275,000	25,703,000	25,130,000	15,464,000	12,316,000	10,456,000	6,642,000	5,436,000	6,294,000	8,523,000	6,436,000	5,906,000	3,915,390	3,364,000	8,639,000	30,633,000	32,525,000	30,920,000	32,961,000	32,666,000	32,365,000	25,931,000	20,071,000	16,551,000	18,965,000	18,254,000	15,644,000	17,116,000	15,349,000	17,314,000	12,267,000	13,037,000	17,759,000		15,871,000
long term liabilities:
loan payable, net of discount	118,376,000	118,005,000	117,569,000	117,087,000	116,607,000	116,135,000	115,480,000	114,727,000	99,249,000	83,965,000	49,289,000	48,983,000	48,670,000
total long term liabilities	122,900,000	118,755,000	118,587,000	118,263,000	117,507,000	117,180,000	116,666,000	116,050,000	99,249,000	83,965,000	49,289,000	49,054,000	48,848,000	283,000	387,000	491,000	594,000	387,000	468,000	548,000	197,000	279,000	361,000	441,000	520,000	598,000
total liabilities	319,403,000	285,992,000	287,864,000	296,110,000	242,669,000	231,521,000	235,214,000	215,715,000	198,955,000	182,313,000	165,183,000	147,974,000	132,857,000	76,918,000	77,225,000	69,816,000	57,304,000	49,178,000	47,025,000	49,913,000	45,472,000	25,982,000	25,491,000	15,905,000	12,836,000	11,054,000	6,642,000	5,436,000	6,294,000	8,523,000	6,436,000	5,906,000	3,915,390	3,364,000	8,639,000	30,644,000	32,557,000	33,252,000	39,928,000	41,948,000	43,960,000	42,051,000	38,488,000	37,096,000	25,423,000	26,700,000	26,071,000	29,287,000	29,184,000	29,825,000	17,031,000	19,153,000	26,726,000		19,139,000
stockholders’ equity:
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at june 30, 2025 and december 31, 2024; 2,369,797 and 2,369,797 shares issued and outstanding at june 30, 2025 and december 31, 2024, respectively
common stock	2,000	2,000	2,000	2,000	2,000	2,000	2,000	2,000	2,000	2,000	2,000	2,000	2,000	2,000	2,000	2,000	2,000	2,000	2,000	2,000	2,000	2,000	2,000	2,000	2,000	2,000	2,000	2,000	1,000	1,000	1,000	1,000	1,157	14,000	14,000	14,000	13,000	11,000	11,000	10,000	9,000	7,000	7,000	7,000	6,000	6,000	6,000	5,000	5,000	4,000	4,000	4,000			3,000
additional paid-in-capital	2,612,566,000	2,585,666,000	2,556,095,000	2,518,648,000	2,493,288,000	2,334,760,000	1,741,153,000	1,246,385,000	1,228,949,000	1,189,776,000	1,160,079,000	887,660,000	879,538,000	870,972,000	863,495,000	837,636,000	810,295,000	738,575,000	665,385,000	655,622,000	650,211,000	644,413,000	639,567,000	635,535,000	630,550,000	622,678,000	610,845,000	605,418,000	290,182,000	152,276,000	151,247,000	115,692,000	105,161,301	757,626,000	757,081,000	756,053,000	747,055,000	704,403,000	700,927,000	671,240,000	613,180,000	541,849,000	540,155,000	538,538,000	475,273,000	448,555,000	447,226,000	412,262,000	411,375,000	375,545,000	367,480,000	366,276,000	337,376,000
accumulated other comprehensive income	1,111,000	389,000	468,000	1,271,000	-368,000	-172,000	468,000																							47,000	36,000	64,000		81,000	4,000	11,000		6,000	11,000	3,000	4,000	6,000	9,000	7,000	8,000	4,000	19,000	1,000	10,000	3,000			3,000
accumulated deficit	-1,917,701,000	-1,875,420,000	-1,802,182,000	-1,742,766,000	-1,635,802,000	-1,483,831,000	-1,336,290,000	-1,224,096,000	-1,125,356,000	-1,039,556,000	-962,660,000	-876,755,000	-795,558,000	-724,828,000	-667,310,000	-602,761,000	-539,661,000	-478,010,000	-425,464,000	-366,341,000	-308,378,000	-259,355,000	-223,220,000	-195,480,000	-174,051,000					-98,016,000
total stockholders’ equity	695,978,000	710,637,000	754,383,000	777,155,000	857,120,000	850,759,000	405,333,000	22,249,000	103,506,000	150,136,000	197,389,000	10,670,000	83,535,000	145,744,000	196,107,000	234,881,000	270,651,000	260,553,000	239,970,000	289,704,000	342,916,000	385,475,000	416,565,000	440,349,000	456,986,000	468,506,000	482,907,000	486,092,000	177,184,000	54,308,000	61,631,000	34,451,000	37,591,794	41,574,000	44,331,000	60,370,000	68,982,000	46,140,000	83,728,000	73,998,000	38,224,000	14,612,000	35,436,000	56,604,000	32,190,000	20,464,000	33,770,000	24,581,000	36,437,000	13,101,000	35,519,000	43,389,000	30,836,000		52,461,000
total liabilities and stockholders’ equity	1,015,381,000	996,629,000	1,042,247,000	1,073,265,000	1,099,789,000	1,082,280,000	640,547,000	237,964,000	302,461,000	332,449,000	362,572,000	158,644,000	216,392,000	222,662,000	273,332,000	304,697,000	327,955,000	309,731,000	286,995,000	339,617,000	388,388,000	411,457,000	442,056,000	456,254,000	469,822,000	479,560,000	489,549,000	491,528,000	183,478,000	62,831,000	68,067,000	40,357,000	41,507,184	44,938,000	52,970,000	91,014,000	101,539,000	79,392,000	123,656,000	115,946,000	82,184,000	56,663,000	73,924,000	93,700,000	57,613,000	47,164,000	59,841,000	53,868,000	65,621,000	42,926,000	52,550,000	62,542,000	57,562,000		71,600,000
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at march 31, 2025 and december 31, 2024; 2,369,797 and 2,369,797 shares issued and outstanding at march 31, 2025 and december 31, 2024, respectively
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at december 31, 2024 and december 31, 2023; 2,369,797 and 2,369,797 shares issued and outstanding at december 31, 2024 and december 31, 2023, respectively
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at september 30, 2024 and december 31, 2023; 2,369,797 and 2,369,797 shares issued and outstanding at september 30, 2024 and december 31, 2023, respectively
accrued expenses					115,611,000	92,271,000	89,980,000	82,610,000	81,761,000	85,567,000	91,461,000	79,598,000	71,836,000	53,442,000	55,048,000	58,501,000	55,240,000	44,075,000	45,222,000	42,773,000	39,948,000	24,269,000	23,637,000	14,381,000	11,564,000	5,778,000	5,611,000	4,848,000	4,874,000	7,123,000	5,151,000	3,126,000	2,755,554																						9,619,000
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at june 30, 2024 and december 31, 2023; 2,369,797 and 2,369,797 shares issued and outstanding at june 30, 2024 and december 31, 2023, respectively
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at march 31, 2024 and december 31, 2023; 2,369,797 and 2,369,797 shares issued and outstanding at march 31, 2024 and december 31, 2023, respectively
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at december 31, 2023 and december 31, 2022; 2,369,797 and 2,369,797 shares issued and outstanding at december 31, 2023 and december 31, 2022, respectively
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at september 30, 2023 and december 31, 2022; 2,369,797 and 2,369,797 shares issued and outstanding at september 30, 2023 and december 31, 2022, respectively
accumulated other comprehensive loss								-42,000	-89,000	-86,000	-32,000	-237,000	-447,000
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at june 30, 2023 and december 31, 2022; 2,369,797 and 2,369,797 shares issued and outstanding at june 30, 2023 and december 31, 2022, respectively
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at march 31, 2023 and december 31, 2022; 2,369,797 and 2,369,797 shares issued and outstanding at march 31, 2023 and december 31, 2022, respectively
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at december 31, 2022 and december 31, 2021; 2,369,797 and 1,969,797 shares issued and outstanding at december 31, 2022 and december 31, 2021, respectively
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at september 30, 2022 and december 31, 2021; 1,969,797 shares issued and outstanding at september 30, 2022 and december 31, 2021
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at june 30, 2022 and december 31, 2021; 1,969,797 shares issued and outstanding at june 30, 2022 and december 31, 2021
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at march 31, 2022 and december 31, 2021; 1,969,797 shares issued and outstanding at march 31, 2022 and december 31, 2021
accumulated other comprehensive gain														-402,000	-80,000	4,000	15,000	-14,000	47,000	421,000	1,081,000	415,000	216,000	292,000	485,000	178,000
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at december 31, 2021 and december 31, 2020; 1,969,797 shares issued and outstanding at december 31, 2021 and december 31, 2020
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at september 30, 2021 and december 31, 2020; 1,969,797 shares issued andoutstanding at september 30, 2021 and december 31, 2020
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at june 30, 2021 and december 31, 2020; 1,969,797 shares issued and outstanding at june 30, 2021 and december 31, 2020
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at march 31, 2021 and december 31, 2020; 1,969,797 shares issued and outstanding at march 31, 2021 and december 31, 2020
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at december 31, 2020 and december 31, 2019; 1,969,797 shares issued and outstanding at december 31, 2020 and december 31, 2019
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at september 30, 2020 and december 31, 2019; 1,969,797 shares issued and outstanding at september 30, 2020 and december 31, 2019
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at june 30, 2020 and december 31, 2019; 1,969,797 shares issued and outstanding at june 30, 2020 and december 31, 2019
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at march 31, 2020 and december 31, 2019; 1,969,797 shares issued and outstanding at march 31, 2020 and december 31, 2019
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at december 31, 2019 and december 31, 2018; 1,969,797 shares issued and outstanding at december 31, 2019 and december 31, 2018
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at september 30, 2019 and december 31, 2018; 1,969,797 shares issued and outstanding at september 30, 2019 and december 31, 2018
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at june 30, 2019 and december 31, 2018; 1,969,797 shares issued and outstanding at june 30, 2019 and december 31, 2018
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at march 31, 2019 and december 31, 2018; 1,969,797 shares issued and outstanding at march 31, 2019 and december 31, 2018
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at september 30, 2018 and december 31, 2017; 1,969,797 shares issued and outstanding at september 30, 2018 and december 31, 2017
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at june 30, 2018 and december 31, 2017; 1,969,797 shares issued and outstanding at june 30, 2018 and december 31, 2017
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at march 31, 2018 and december 31, 2017; 1,969,797 shares issued and outstanding at march 31, 2018 and december 31, 2017
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at september 30, 2017 and december 31, 2016; 1,969,797 and no shares issued and outstanding at september 30, 2017 and december 31, 2016, respectively
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at june 30, 2017 and december 31, 2016; 1,969,797 and no shares issued and outstanding at june 30, 2017 and december 31, 2016, respectively
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at march 31, 2017 and december 31, 2016; no shares issued and outstanding at each of march 31, 2017 and december 31, 2016
other receivable — related party
goodwill and other intangibles assets																																	315,070
liabilities and stockholders’ deficit
convertible promissory notes payable — related parties
advances payable — related party
accrued interest on advances — related party
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at september 30, 2016 and december 31, 2015; no shares issued and outstanding at each of september 30, 2016 and december 31, 2015
accrued contract research costs																																		1,202,000	2,737,000	17,206,000	14,728,000	12,511,000	14,276,000	12,987,000	12,488,000	8,352,000	5,911,000	4,901,000	3,719,000	3,776,000	4,007,000	3,010,000	2,871,000	3,253,000	2,535,000	2,591,000	2,854,000
other accrued liabilities																																		1,450,000	2,826,000	5,047,000	5,529,000	5,408,000	4,994,000	5,212,000	4,765,000	4,497,000	3,624,000	2,839,000	3,643,000	3,119,000	2,530,000	3,249,000	2,909,000	2,152,000	2,802,000	3,226,000	4,125,000
current portion of capital lease obligations																																		22,000	33,000	43,000	43,000	42,000	42,000	41,000	41,000	4,000	8,000	11,000	13,000
current portion of term loans																																		10,000	2,299,000	6,913,000	9,207,000	9,221,000	9,207,000	9,200,000	9,261,000	7,385,000	5,306,000	3,081,000	7,900,000	7,878,000	6,055,000	4,613,000	3,093,000	5,529,000
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at june 30, 2016 and december 31, 2015; no shares issued and outstanding at each of june 30, 2016 and december 31, 2015
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at march 31, 2016 and december 31, 2015; no shares issued and outstanding at each of march 31, 2016 and december 31, 2015
other assets																																				226,000	278,000	564,000	331,000	358,000	384,000	433,000	464,000	481,000	466,000	503,000	519,000	530,000	497,000	417,000	151,000	151,000	68,000		87,000
long-term liabilities:
capital lease obligations, net of current portion																																				11,000	22,000	33,000	54,000	65,000	75,000				4,000
term loans, net of current portion																																					10,000	2,299,000	6,913,000	9,217,000	11,520,000	16,120,000	18,417,000	20,545,000	6,454,000	8,438,000	10,416,000	12,154,000	13,815,000	11,471,000
total long-term liabilities																																				11,000	32,000	2,332,000	6,967,000	9,282,000	11,595,000	16,120,000	18,417,000	20,545,000	6,458,000	8,446,000	10,427,000	12,171,000	13,835,000	12,511,000	4,764,000	6,116,000	8,967,000
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at each of september 30, 2015 and december 31, 2014; no shares issued and outstanding at each of september 30, 2015 and december 31, 2014
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at each of june 30, 2015 and december 31, 2014; no shares issued and outstanding at each of june 30, 2015 and december 31, 2014
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at march 31, 2015 and december 31, 2014; no shares issued and outstanding at each of march 31, 2015 and december 31, 2014
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at september 30, 2014 and december 31, 2013; no shares issued and outstanding at september 30, 2014 and december 31, 2013
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at june 30, 2014 and december 31, 2013; no shares issued and outstanding at june 30, 2014 and december 31, 2013
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at march 31, 2014 and december 31, 2013; no shares issued and outstanding at march 31, 2014 and december 31, 2013
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at september 30, 2013 and december 31, 2012; no shares issued and outstanding at september 30, 2013 and december 31, 2012
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at june 30, 2013 and december 31, 2012; no shares issued and outstanding at june 30, 2013 and december 31, 2012
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at march 31, 2013 and december 31, 2012; no shares issued and outstanding at march 31, 2013 and december 31, 2012
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at september 30, 2012 and december 31, 2011; no shares issued and outstanding at september 30, 2012 and december 31, 2011
capital lease obligations																																														13,000	12,000	20,000	31,000	117,000	1,078,000	1,185,000	1,352,000
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at june 30, 2012 and december 31, 2011; no shares issued and outstanding at june 30, 2012 and december 31, 2011
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at march 31, 2012 and december 31, 2011; no shares issued and outstanding at march 31, 2012 and december 31, 2011
collaboration receivable
deferred collaboration revenue																																																3,303,000	4,446,000	4,572,000	4,572,000	4,573,000	4,892,000
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at september 30, 2011 and december 31, 2010; no shares issued and outstanding at september 30, 2011 and december 31, 2010
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at june 30, 2011 and december 31, 2010; no shares issued and outstanding at june 30, 2011 and december 31, 2010
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at march 31, 2011 and december 31, 2010; no shares issued and outstanding at march 31, 2011 and december 31, 2010
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at june 30, 2010 and december 31, 2009; no shares issued and outstanding at june 30, 2010 and december 31, 2009
preferred stock, par value 0.0001 per share authorized: 5,000,000 shares at march 31, 2010 and december 31, 2009; no shares issued and outstanding at march 31, 2010 and december 31, 2009
deferred collaboration revenue—long-term																																																					7,875,000
collaboration payable—long-term
capital lease obligations—long-term																																																					1,092,000		3,268,000
stockholders’ equity
preferred stock, par value 0.0001 per share
authorized: 5,000,000 shares at september 30, 2009 and december 31, 2008; no shares issued and outstanding at september 30, 2009 and december 31, 2008
authorized: 100,000,000 shares at september 30, 2009 and december 31, 2008; 33,978,300 and 33,919,584 shares issued and outstanding at september 30, 2009 and december 31, 2008, respectively																																																					3,000
stockholders' equity
marketable securities available-for-sale
deferred offering costs
capital lease obligations—current																																																							2,440,000
other current liabilities																																																							1,831,000
deferred revenue
convertible preferred stock, at redemption value:
series a convertible preferred stock, 0.0001 par value per share. authorized: no shares at june 30, 2007 and 8,000,000 shares at december 31, 2006; no shares issued and outstanding at june 30, 2007 and 8,000,000 shares issued and outstanding at december 31, 2006
preferred stock, par value 0.0001 per share. authorized 5,000,000 shares at june 30, 2007 and no shares at december 31, 2006; no shares issued and outstanding at june 30, 2007 and at december 31, 2006
additional paid-in capital																																																							322,111,000
deficit accumulated during the development stage

We provide you with 20 years of balance sheets for Madrigal Pharmaceuticals stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Madrigal Pharmaceuticals. Explore the full financial landscape of Madrigal Pharmaceuticals stock with our expertly curated balance sheets.

The information provided in this report about Madrigal Pharmaceuticals stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.